FOSTER CITY, Calif. -- Sept. 29, 2021-- Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved...
Scott Weiner to join panel at 2nd Annual Global Healthcare Investing Conference
News | 04. 30. 2008
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.